A sweeping review of previous research suggests commonly prescribed opioids often provide only modest pain relief and may increase side effect risk.
Last summer, the Trump administration announced a voluntary pledge by health insurers to reform prior authorization, but patient advocates and medical providers remain skeptical.
Webinar will include a review of full-year 2025 and fourth quarter 2025 financial results, a deep dive into the equine veterinary market and Zomedica's equine-focused product portfolio, along with a ...
1 天on MSN
New NHS MRI machine to be installed at Leatherhead Leisure Centre in bid to tackle wait lists
A new MRI scanner is to be built in Leatherhead after a review found missed waiting time targets and shortfall in access ...
In a dvm360 interview, recorded at the 2026 Veterinary Meeting & Expo (VMX) in Orlando, Florida, Dottie Brown, DVM, MS, DACVS, vice president of science and innovation for Mars Veterinary Health, ...
F10 Antiseptic Wound Spray with Insecticide received the EUA based on scientific evidence available. The FDA announced earlier this week it issued an Emergency Use Authorization (EUA) for benzalkonium ...
The FDA has approved teclistamab (Tecvayli) daratumumab and hyaluronidase-fihj (Darzalex Faspro) for the treatment of ...
About one in three Americans who use CBD say they take it as an alternative or supplement to at least one ...
In a letter to Ekirch confirming the external reviewer’s decision, Anthem explained that the authorization would be valid for a year beginning on Sept. 25, 2025. “We are pleased we can provide a ...
Health eCareers on MSN
The new career paths opening for PTs and OTs in digital health
Digital health is expanding rapidly, moving beyond video visits and app-based check-ins. Rehab companies, hospital systems, start-ups, and insurers are forging care pathways around remote and hybrid ...
To say 2025 was a busy news year would be an understatement. There were wildfires and hurricanes and plenty of political intrigue. We also enjoyed some memorable moments in sports and entertainment.
LOS ANGELES and PARIS, March 02, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a U.S. leader in outpatient diagnostic imaging services, announced today it has acquired Gleamer SAS ( ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果